Non-insulin type 2 diabetes patients using CGM have lower HbA1c at 26 weeks

Researchers reported 14 October 2026 found a 0.9 percentage point reduction relative to routine care.

Sarah Lindqvist-Park

Clinical Nutrition Writer

Share on X

Stands on 2 placed sources from 2 publishers.

Diabetes patients see improvement with glucose monitors AI illustrationhow this picture was made

Researchers led by Roy W. Beck at the Jaeb Center for Health Research reported on 14 October 2026 that non-insulin type 2 diabetes patients using continuous glucose monitors had 0.9 percentage points lower HbA1c at 26 weeks compared to patients receiving routine care. ^[1] The analysis drew on electronic health records for 17,499 type 2 diabetes patients across 10 mid-Atlantic primary care practices. ^[2]

Proof2 sources · 2 publishers · signed

What this stands on

Roy W. Beck and Jaeb Center for Health Research researchers reported on 2026-10-14 that non-insulin type 2 diabetes patients using CGM had 0.9 percentage point lower HbA1c at 26 weeks versus routine care. · MedpageToday
Researchers analyzed electronic health records for 17,499 type 2 diabetes patients across 10 mid-Atlantic primary care practices. · Medical Xpress

We could not place any of them by their address. None is an official body: that part stands on reporting, not on the underlying document or transcript.